Physician profile
Yi Meng Yen
NPI 1881707974
$52,232.37
in general payments reported to CMS, 2019-2025
8 companies · $5,794 in 2025
The $5,794 reported for 2025 was more than what 82% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $22K · 2021: $7,005 · 2022: $146 · 2023: $6,690 · 2024: $10K · 2025: $5,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $1,494 · Travel and Lodging: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,106.25 |
| Food and Beverage | $1,494.08 |
| Travel and Lodging | $1,109.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $46,590.46 | 2019-2025 | Accu-Pass, Q-Fix, The Pink Hip Kit - Smith & Nephew Table |
| Stryker Corporation | $2,772.55 | 2019-2025 | Salvation, Iconix, Alphavent |
| Orthopediatrics Corp. | $1,472.53 | 2023-2025 | |
| Kairos Surgical INC | $1,298.19 | 2020 | |
| Steris Corporation | $40.00 | 2020 | |
| Vericel Corporation | $37.46 | 2019 | |
| Bioventus LLC | $21.18 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Meng Yen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.